✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Arcus Biosciences, Inc.

Common Name
Arcus Biosciences
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
601
Ticker
RCUS
Exchange
New York Stock Exchange
Description
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing cancer immunotherapies and combination medicines. The company is building a portfolio of differentiated smal...

Arcus Biosciences's Revenues Data

Explore Arcus Biosciences's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
247,000,000a
258,000,000a
117,000,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Arcus Biosciences’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Arcus Biosciences's 10-K 2025